Five-year safety and performance results from the Argus II Retinal Prosthesis System clinical trial

PURPOSE: The Argus(®) II Retinal Prosthesis System (Second Sight Medical Products, Inc., Sylmar, CA) was developed to restore some vision to patients blind from retinitis pigmentosa (RP) or outer retinal degeneration. A clinical trial was initiated in 2006 to study the long-term safety and efficacy...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Ophthalmology
Autori principali: da Cruz, Lyndon, Dorn, Jessy D., Humayun, Mark S., Dagnelie, Gislin, Handa, James, Barale, Pierre-Olivier, Sahel, José-Alain, Stanga, Paulo E., Hafezi, Farhad, Safran, Avinoam B., Salzmann, Joel, Santos, Arturo, Birch, David, Spencer, Rand, Cideciyan, Artur V., de Juan, Eugene, Duncan, Jacque L., Eliott, Dean, Fawzi, Amani, Olmos de Koo, Lisa C., Ho, Allen C., Brown, Gary, Haller, Julia, Regillo, Carl, Del Priore, Lucian V., Arditi, Aries, Greenberg, Robert J.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5035591/
https://ncbi.nlm.nih.gov/pubmed/27453256
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ophtha.2016.06.049
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi